A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
Study Information
Alliance Study ID: AFT-19
NCT Study ID (ClinicalTrials.gov): NCT03009981
Alliance Committee: Genitourinary Cancer
Disease or Cancer Type: Prostate Cancer
Alliance Study Chair: Rahul Aggarwal, MD
Status: COMPLETED
Study Description
This is a randomized, open-label, three-arm, phase 3 study in men with biochemically recurrent prostate cancer and PSA doubling time ≤ 9 months at the time of study entry.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information